Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy-Reference-Cited by-同舟云学术

Traffic lights for retinoids in oncology: molecular markers of retinoid resistance and sensitivity and their use in the management of cancer differentiation therapy

Published:2018-11-01 Issue:1 Volume:18 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Dobrotkova Viera,Chlapek Petr,Mazanek Pavel,Sterba Jaroslav,Veselska Renata

Funder

Ministerstvo Zdravotnictví Ceské Republiky

Ministerstvo Školství, Mládeže a Tělovýchovy

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/s12885-018-4966-5.pdf

Reference122 articles.

1. Nowak D, Stewart D, Koeffler HP. Differentiation therapy of leukemia: 3 decades of development. Blood. 2009;113:3655–65.

2. Koeffler HP. Induction of differentiation of human acute myelogenous leukemia cells: therapeutic implications. Blood. 1983;62:709–21.

3. Dragnev KH, Rigas JR, Dmitrovsky E. The Retinoids and cancer prevention mechanisms. Oncologist. 2000;5:361–8.

4. Sakashita A, Kizaki M, Pakkala S, Schiller G, Tsuruoka N, Tomosaki R, et al. 9-cis-retinoic acid: effects on normal and leukemic hematopoiesis in vitro. Blood. 1993;81:1009–16.

5. Khan AA, Villablanca JG, Reynolds CP, Avramis VI. Pharmacokinetic studies of 13-cis-retinoic acid in pediatric patients with neuroblastoma following bone marrow transplantation. Cancer Chemother Pharmacol. 1996;39:34–41.

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining neuroblastoma: from origin to precision medicine;Neuro-Oncology;2024-08-05

2. Developing targeted therapies for neuroblastoma by dissecting the effects of metabolic reprogramming on tumor microenvironments and progression;Theranostics;2024

3. Development and Challenges of Synthetic Retinoid Formulations in Cancer;Current Drug Delivery;2023-11

4. Characterization and therapeutic perspectives of differentiation-inducing therapy in malignant tumors;Frontiers in Genetics;2023-09-08

5. Discovery of novel RARα agonists using pharmacophore-based virtual screening, molecular docking, and molecular dynamics simulation studies;PLOS ONE;2023-08-24